<DOC>
	<DOC>NCT02481232</DOC>
	<brief_summary>Safety Evaluation of freeze-dried Group ACYW135 Meningococcal conjugate vaccine in healthy people above 2-months-old</brief_summary>
	<brief_title>A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine</brief_title>
	<detailed_description>There are five different age groups(18~55 years/7~17 years/1~6 years/7~10 months/2 months),each group has 40 people and divided into two subgroups. Each subgroup will inject different vaccine(MCV4 4μg,MCV4 8μg).For 7~10 months&amp;2 months age groups,there are 2&amp;3 injection seperately. Each injection interval is 1 months. After 7 days observation of 1 dose immunization in Group 18-55 years old adults, if there are no serious adverse events associated with vaccines, or severe adverse reactions rate is less than 10%, 7 to 17 years old and 1 to 6 years old age groups will continue to inoculate in order. After the first dose of 7~10 months group and evaluating safety, 2 months group immunized the first dose. All participants completed the immune procedure, then observed the safety to 30 days after whole immunization. Data collection: Subjects completed diary card, the researchers collected original data and fill out the case report form for data entry and statistical analysis.</detailed_description>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis, Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infants unimmunized Group A&amp;C meningococcal conjugate vaccine or Group A meningococcal polysaccharide vaccine which is above 2~11 monthsold, and healthy toddler more than 1yearold without booster immunization. The guardian or himself informed consent, and signed the informed consent form; The guardian and family agreed to abide by the requirements of clinical trial scheme; Participants has no history of immunoglobulin vaccination in the last 2 months / 2 monthsold infants has no history of immunoglobulin vaccination after born, there is no history of other live vaccine inoculation before vaccination in 14 days, within 7 days without other inactivated vaccine immunization history; the axillary temperature &lt; 37.1 ℃; 2monthsold group in the age of 6190 days; 7monthsold group in the age of 211300 days; 1yearold group in age of one full year of life. Have allergies, convulsions, seizures, encephalopathy and psychiatric history or family history; Neomycin, streptomycin and polymyxin B allergies; With immunodeficiency, immunosuppressant therapy; History of meningitis; Women in lactation or pregnant; Acute febrile diseases and infectious diseases; History of labor abnormalities, choking rescue, congenital malformations, developmental disorders or serious chronic disease patients; Had a severe allergic reaction of vaccination in the past; Took oral steroids more than 14 days in last month; Had high fever (axillary temperature≥38.0℃ or higher)in the past three days; Prepare to attend or is in any other drug clinical study; Meningococcal vaccine contraindications and any situation which researchers think that may affect test evaluation.</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>